Drug Research

The 77th World Health Assembly- WHA goes on to mark the deadline for the conclusion of a pandemic agreement as well as amended International Health Regulations 2005 that look to make the planet much better prepared for the next...

Belgium-headquartered Exothera, a leading provider of nucleic acids and viral vector development and manufacturing services, has launched its game-changing nucleic acids service offering, powered by the world's first continuous-batch RNA production platform, Ntensify™. Developed by Exothera sister company Quantoom...

No company happened to be hit harder by the US Federal Trade Commission’s crackdown when it came to patents listed on the federal registry of approved drugs than Teva Pharmaceutical Industries Ltd., the Israeli drugmaker, and the fact that...

Hovione, the specialist integrated CDMO and leader in spray drying and particle engineering, and GEA, a global leader in process technology for the pharmaceutical industry announced the next stage of their partnership, with new development agreements, the launch of...

ReciBioPharm, the advanced and emerging therapies business unit of Recipharm, has announced a collaboration agreement with GeneVentiv Therapeutics, a pre-clinical gene therapy company, to advance development of an Adeno-Associated Virus (AAV)-based universal gene therapy for haemophilia, and the first...

Robust trend has been seen to invest in platform technologies, both in numbers and deal values. By 2023 end, 76 cell & gene therapies have been launched across the globe more than twice of what was witnessed in 2011. It is...

Berry Global, a leader in the design, development, and production of patient-centred healthcare solutions, recently launched the BerryHaler, a dual chamber, dry powder inhaler (DPI) with a dose counter designed to provide better patient access to and support the...